DURECT Corporation (DRRX) Reports Smaller-Than-Expected Loss on Higher Revenues
More News related to DRRX
- DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial
- DURECT (DRRX) Reports Positive Phase IIb Results from POSIDUR Clinical
- DURECT Reports Positive Phase IIb Data from POSIDUR(TM) Clinical Program
- DURECT Corporation (DRRX) Reports Smaller-Than-Expected Loss on Higher Revenues
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
DURECT Corporation (NASDAQ: DRRX) reports a Q3 loss of $0.07, 2 cents better than the analyst estimate of ($0.09). Revenue for the quarter was $8.4 million, which compares to the estimate of $6.13 million.
Related Categories
EarningsStocks Mentioned
+0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
